2025-01-10 IDOPRESS
SINGAPORE,Jan. 9,2025 --BIGO AdsSDK is now an approved bidding partner for Unity LevelPlay,a leading mediation platform. This collaboration brings together BIGO Ads' vast ad inventory and LevelPlay's massive traffic,empowering developers to enhance their revenue potential and optimize their user experience.
What benefits from integrating BIGO Ads?
BIGO Ads provides a reliable and secure SDK that empowers developers and advertisers to achieve sustainable growth.
For app developers:
If you're already using Unity LevelPlay,integrating the BIGO Ads SDK is fast and hassle-free.
Adding bidding ad sources increases competition,helping you maximize ad revenue.
For advertisers:
Gain access to high-quality traffic from Unity LevelPlay and premium ad placements across 30,000+ apps partnered with BIGO Ads to boost campaign performance.
What Our Partners Are Saying
Ashley Navon,Senior Director of Growth Partnerships,Unity
"We're delighted to bring BIGO Ads into Unity LevelPlay. The addition of their global demand in our mediation will help boost the bids and ultimately the revenue for our developers and publishers."
Eden Liu,Head of BD,BIGO Ads
"Our team is excited to partner with LevelPlay. Collaborating with LevelPlay has been seamless,and their efficiency and professionalism are outstanding. We believe this integration will unlock significant value for developers and advertisers alike."
INDIEZ Team

Cangxi County Holds 2026 New Year's Cultural Performance for the Public
The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange
Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement
©copyright 2009-2020 Singapore Info Map